Objectives To evaluate the cost-effectiveness of anti-vascular endothelial growth factor (VEGF) treatments for neovascular age-related macular degeneration (nAMD) using a value-based model that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results